NFKB1 and neoplasm: Interestingly, we showed, for the first time, that the risk for relapse is around three times as high in the group NF-κB positive when compared to NF-κB negative, and this difference remains even after the adjustment of a potential factor of influence, with the exception of the tumor maker LDH (Figure-2B).